1. Home
  2. FTRE vs ECX Comparison

FTRE vs ECX Comparison

Compare FTRE & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • ECX
  • Stock Information
  • Founded
  • FTRE 1996
  • ECX 2017
  • Country
  • FTRE United States
  • ECX China
  • Employees
  • FTRE N/A
  • ECX N/A
  • Industry
  • FTRE Medical Specialities
  • ECX EDP Services
  • Sector
  • FTRE Health Care
  • ECX Technology
  • Exchange
  • FTRE Nasdaq
  • ECX Nasdaq
  • Market Cap
  • FTRE 701.9M
  • ECX 600.6M
  • IPO Year
  • FTRE N/A
  • ECX N/A
  • Fundamental
  • Price
  • FTRE $10.20
  • ECX $1.82
  • Analyst Decision
  • FTRE Hold
  • ECX Strong Buy
  • Analyst Count
  • FTRE 9
  • ECX 1
  • Target Price
  • FTRE $12.06
  • ECX $3.20
  • AVG Volume (30 Days)
  • FTRE 1.9M
  • ECX 2.5M
  • Earning Date
  • FTRE 11-07-2025
  • ECX 11-06-2025
  • Dividend Yield
  • FTRE N/A
  • ECX N/A
  • EPS Growth
  • FTRE N/A
  • ECX N/A
  • EPS
  • FTRE N/A
  • ECX N/A
  • Revenue
  • FTRE $2,733,500,000.00
  • ECX $796,102,682.00
  • Revenue This Year
  • FTRE N/A
  • ECX $824.91
  • Revenue Next Year
  • FTRE N/A
  • ECX $30.72
  • P/E Ratio
  • FTRE N/A
  • ECX N/A
  • Revenue Growth
  • FTRE N/A
  • ECX 11.94
  • 52 Week Low
  • FTRE $3.97
  • ECX $0.76
  • 52 Week High
  • FTRE $25.28
  • ECX $3.25
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 62.69
  • ECX 63.27
  • Support Level
  • FTRE $9.42
  • ECX $1.50
  • Resistance Level
  • FTRE $10.57
  • ECX $1.62
  • Average True Range (ATR)
  • FTRE 0.64
  • ECX 0.11
  • MACD
  • FTRE -0.09
  • ECX 0.03
  • Stochastic Oscillator
  • FTRE 48.26
  • ECX 100.00

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: